Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Quiliano

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Frontiers in Microbiology|July 15, 2021
A Complementary Mechanism of Bacterial mRNA Translation Inhibition by TetracyclinesVictor Barrenechea, Maryhory Vargas-Reyes, Miguel Quiliano, et al.
Malaria Journal|June 21, 2019
Primaquine-quinoxaline 1,4-di-N-oxide hybrids with action on the exo-erythrocytic forms of Plasmodium induce their effect by the production of reactive oxygen speciesLeonardo Bonilla-Ramírez, Silvia Galiano, Miguel Quiliano, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|December 8, 2009
Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistanceMirko Zimic, Patricia Sheen, Miguel Quiliano, et al.
Memorias Do Instituto Oswaldo Cruz|September 20, 2012
The in vivo antimalarial activity of methylene blue combined with pyrimethamine, chloroquine and quinineGiovanny Garavito, Stéphane Bertani, Miguel Quiliano, et al.
Scientific Reports|May 28, 2026
A framework for the development and validation of an aptamer-based assay for pathogen detection using SARS-CoV-2 as a modelSteev Loyola, Leonardo J Monroy-Cruz, Miguel Quiliano, et al.
Journal of Computer-Aided Molecular Design|April 14, 2011
Docking and quantitative structure-activity relationship studies for 3-fluoro-4-(pyrrolo[2,1-f][1,2,4]triazin-4-yloxy)aniline, 3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)aniline, and 4-(4-amino-2-fluorophenoxy)-2-pyridinylamine derivatives as c-Met kinase inhibitorsJulio Caballero, Miguel Quiliano, Jans H Alzate-Morales, et al.
ACS Omega|June 20, 2022
Identifying RO9021 as a Potential Inhibitor of PknG from <i>Mycobacterium tuberculosis</i>: Combinative Computational and In Vitro StudiesAlicia Arica-Sosa, Roberto Alcántara, Gabriel Jiménez-Avalos, et al.
Journal of Biomolecular Structure & Dynamics|April 30, 2026
A useful guide for medicinal chemists to design PknG inhibitors: structure-activity relationships, structural requirements and molecular dynamics simulationsAlicia Arica-Sosa, Leonardo J Monroy-Cruz, Roberto Alcántara, et al.
Plos One|April 15, 2017
Mathematical algorithm for the automatic recognition of intestinal parasitesAlicia Alva, Carla Cangalaya, Miguel Quiliano, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2017
New hydrazine and hydrazide quinoxaline 1,4-di-N-oxide derivatives: In silico ADMET, antiplasmodial and antileishmanial activityMiguel Quiliano, Adriana Pabón, Gustavo Ramirez-Calderon, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Frontiers in Microbiology|July 15, 2021
A Complementary Mechanism of Bacterial mRNA Translation Inhibition by TetracyclinesVictor Barrenechea, Maryhory Vargas-Reyes, Miguel Quiliano, et al.
Malaria Journal|June 21, 2019
Primaquine-quinoxaline 1,4-di-N-oxide hybrids with action on the exo-erythrocytic forms of Plasmodium induce their effect by the production of reactive oxygen speciesLeonardo Bonilla-Ramírez, Silvia Galiano, Miguel Quiliano, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|December 8, 2009
Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistanceMirko Zimic, Patricia Sheen, Miguel Quiliano, et al.
Memorias Do Instituto Oswaldo Cruz|September 20, 2012
The in vivo antimalarial activity of methylene blue combined with pyrimethamine, chloroquine and quinineGiovanny Garavito, Stéphane Bertani, Miguel Quiliano, et al.
Scientific Reports|May 28, 2026
A framework for the development and validation of an aptamer-based assay for pathogen detection using SARS-CoV-2 as a modelSteev Loyola, Leonardo J Monroy-Cruz, Miguel Quiliano, et al.
Journal of Computer-Aided Molecular Design|April 14, 2011
Docking and quantitative structure-activity relationship studies for 3-fluoro-4-(pyrrolo[2,1-f][1,2,4]triazin-4-yloxy)aniline, 3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)aniline, and 4-(4-amino-2-fluorophenoxy)-2-pyridinylamine derivatives as c-Met kinase inhibitorsJulio Caballero, Miguel Quiliano, Jans H Alzate-Morales, et al.
ACS Omega|June 20, 2022
Identifying RO9021 as a Potential Inhibitor of PknG from <i>Mycobacterium tuberculosis</i>: Combinative Computational and In Vitro StudiesAlicia Arica-Sosa, Roberto Alcántara, Gabriel Jiménez-Avalos, et al.
Journal of Biomolecular Structure & Dynamics|April 30, 2026
A useful guide for medicinal chemists to design PknG inhibitors: structure-activity relationships, structural requirements and molecular dynamics simulationsAlicia Arica-Sosa, Leonardo J Monroy-Cruz, Roberto Alcántara, et al.
Plos One|April 15, 2017
Mathematical algorithm for the automatic recognition of intestinal parasitesAlicia Alva, Carla Cangalaya, Miguel Quiliano, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2017
New hydrazine and hydrazide quinoxaline 1,4-di-N-oxide derivatives: In silico ADMET, antiplasmodial and antileishmanial activityMiguel Quiliano, Adriana Pabón, Gustavo Ramirez-Calderon, et al.
Pageof 3